Product Information
POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.1025 per EA under NDC 62037055905. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application on Jun 2, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
62037055905
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077419FDA Approved
6/2/2008
TE Code
AB
On Market Since
8/25/2008
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 658 times since Nov 28, 2013, and over the history we have for it it has declined 82.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1025 per EA |
|---|---|
| All-time high | $0.6513 (Aug 10, 2016) |
| All-time low | $0.1025 (Jun 17, 2026) |
| 52-week high | $0.1415 |
| 52-week low | $0.1025 |
| Median price | $0.2866 |
| Average price | $0.3157 |
| Largest weekly change | +73.8% (Apr 18, 2018) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-7.9%
6M
-14.4%
1Y
-27.6%
3Y
-47.7%
5Y
-66.5%
All
-82.9%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Actavis Pharma, Inc., is $0.1025 per EA (NDC 62037055905), effective Jul 1, 2026.
How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 82.9%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?
Since Nov 28, 2013, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.1025 (Jun 17, 2026) to a high of $0.6513 (Aug 10, 2016), with a median of $0.2866 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 8 MEQ CAPSULE, is $0.0936 per EA — about 9% below POTASSIUM CL ER 8 MEQ CAPSULE.
Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?
POTASSIUM CL ER 8 MEQ CAPSULE (NDC 62037055905) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.